Epoetin

This page contains recent news articles, when available, and an overview of Epoetin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Impact of Epoetin-beta on Survival and Tumor Progression Affected by Starting ...  -  05 Jan 2010
Researchers from Germany have reported that epoetin-beta has no adverse affect on survival or tumor progression when initiated at hemoglobin (Hb) levels of ... Cancer Consultants

Bypass Anemia Drugs in Chronic Kidney Disease, Expert Says  -  ‎Dec 24, 2009‎
In CREATE, immediate anemia treatment with epoetin-beta (Micera) targeted to a hemoglobin of 13 to 15 g/dl increased risk of a first cardiovascular adverse ... MedPage Today

Amgen and Hoffman-LaRoche Settle Mircera® Litigation  -  ‎Dec 22, 2009‎
5756349 from infringing said patents by the manufacture, importation, sale, offer for sale or non-exempt use of pegylated Epoetin beta (otherwise referred ... Patent Docs (blog)

A New Look at High Hb Goals  -  ‎Dec 10, 2009‎
...a randomized trial comparing the effect of treatment with epoetin alfa to two Hb targets (11.3 and 13.5 g/L) on the composite end point of death, ... Renal and Urology News

Tired of Being Tired?Cancer-related fatigue doesn't have to slow you down.  -  ‎Dec 23, 2009‎
...available at www.curetoday.com/new_blood), but erythropoiesis-stimulating agents, such as Procrit (epoetin alfa) and Aranesp (darbepoetin alfa), ... Curetoday.com (press release)

New Approach Reduces Number Of Routines Needed To Detect Erythropoietins  -  ‎Dec 17, 2009‎
MIRCERA (methoxy polyethylene glycol-epoetin beta), a PEGylated EPO, is a synthetic protein that helps the body produce red blood cells and used to treat ... Medical News Today (press release)

Researchers discover novel method for detecting MIRCERA  -  ‎Dec 15, 2009‎
MIRCERA (methoxy polyethylene glycol-epoetin beta), a PEGylated EPO, is a synthetic protein that helps the body produce red blood cells and used to treat ... Genetic Engineering News (press release)

A vörösvértest-termelés serkentése hátrányos lehet  -  ‎Dec 28, 2009‎
A CHOIR tanulmány során a betegek epoetin-alfát kaptak, és az elérendő hemoglobin-szint 135 g/l volt. Az epoetin-alfa hatására magasabb lett a halálozási ... medicalonline.hu/

ë‚´ë…„ 제약시장 치료계열별 íŒ?ë?„ ì°¨ì?´  -  ‎Dec 9, 2009‎
...보존치료 분야ì—?ì„  'ì•„ë?¼ë„¤ìŠ¤í”„'와 '프로í?¬ë¦¬íЏ'(Procrit, epoetin alfa)는 안전성 문제로 매출ì?´ 떨어지겠지만 '뉴í?¬ê²?'(Neupogen, filgrastim)ê³¼ '뉴ë?¼ ... 디지틀보사

Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study  -  ‎Nov 11, 2009‎
Amgen's Aranesp (darbepoetin alfa) and Epogen (Epoetin alfa) and Johnson and Johnson's Procrit (Epoetin alfa) are prescribed to patients with kidney disease ... AboutLawsuits.com

Program Found to Improve Cancer-Related Insomnia However, second study finds ...  -  ‎Nov 5, 2009‎
5 (HealthDay News) -- Cancer-related insomnia can be improved by behavioral therapy but not epoetin alfa, according to two studies published online Nov. ... ModernMedicine

ASN: Major Anemia Trial Results Lead to Practice Changes  -  ‎Nov 3, 2009‎
The findings led the FDA to add to the labels of the ESAs epoetin-alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) a boxed warning against aggressively ... MedPage Today

ASN: HCV Changes Dialysis Treatment Needs  -  ‎Oct 30, 2009‎
SAN DIEGO -- Patients on dialysis need less epoetin to treat their anemia if they are infected with hepatitis C (HCV), a researcher reported here. ... MedPage Today

Why Large Doses of IV Iron Decrease HD Patient Survival Is Unclear  -  ‎Nov 1, 2009‎
These patients were much more likely to have received very high doses of epoetin alfa. The researchers ruled out underlying bleeding conditions that ... Renal and Urology News

Comparing ESA Dosing Regimens for Anemic Kidney Disease Patients  -  ‎Oct 21, 2009‎
Although the FDA-approved starting dose of epoetin alfa for the correction of anemia in patients with chronic kidney disease (CKD) is 50-100 IU/kg, ... National Anemia Action Council

Outlining Drug-Induced Anemia and Select Medications  -  ‎Oct 21, 2009‎
Several studies have found that these drugs do not affect the action of epoetin alfa, and that doses and Hb levels are similar among treated and control ... National Anemia Action Council

Anemia Drug May Raise Stroke Risk in Kidney Patients  -  ‎Oct 31, 2009‎
In earlier studies, Aranesp and a similar drug, epoetin alfa, marketed as Procrit or Epogen, were linked to increased risk of death in cancer and stroke ... U.S. News & World Report

Affymax and Takeda Announce Preliminary Phase 2 Data Demonstrated That ...  -  ‎Oct 30, 2009‎
This is the first reported data from an open-label, controlled comparative study of once-monthly Hematide compared to three times per week epoetin alfa ... Reuters

Amgen profit rises, shares decline  -  ‎Oct 22, 2009‎
Sales of Epogen (Epoetin alfa) increased 5% to $663 million in the third quarter of 2009 due to an increase in demand primarily from patient population ... NephrOnline

Affymax and Takeda Announce Hematide Publication in the New England Journal of ...  -  ‎Nov 4, 2009‎
...which can occur when the body produces neutralizing antibodies against the currently marketed recombinant human erythropoietins, such as epoetin alfa or ... Reuters

Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson  -  ‎Nov 11, 2009‎
More worrisome, the workhorse drug Procrit (epoetin alfa) is starting to look like its got a stone embedded in one hoof: this biologic, an injectable ... BNET

Research and Markets: The Congressional Budget Office Estimates the US Could ...  -  ‎Nov 4, 2009‎
Key Topics Covered: * Foreword * Executive Summary * Products in the 'first wave' * Erythropoietin (Epoetin, EPO) * Human Growth Hormone (somatropin) ... Reuters

Higher Hemoglobin May Cut Risk of Death, Dialysis Initiation  -  ‎Oct 30, 2009‎
Ill., studied 208 patients with CKD and anemia, hypothesizing that higher epoetin (EPO) doses would be associated with an increased risk of death or ... Renal and Urology News

Risks outweighed benefits of darbepoetin alfa in patients with type 2 diabetes ...  -  ‎Nov 3, 2009‎
...and Outcomes in Renal Insufficiency (CHOIR) trial, which studied the use of epoetin alfa treatment to achieve two different target hemoglobin levels. ... Endocrine Today

Amgen: Prolia delay further dampens expectations of hyped drug  -  ‎Oct 20, 2009‎
The US biotech has been facing a continuous decline in sales of its leading products Aranesp (darbepoetin alfa) and Epogen (epoetin alfa) and is relying on ... Trading Markets (press release)

Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to ...  -  ‎Oct 21, 2009‎
Sales of EPOGEN(®) (Epoetin alfa) increased 5 percent to $663 million in the third quarter of 2009 versus $634 million in the third quarter of 2008 due to ... Reuters

Phase 2 trail data shows Hematide increases haemoglobin & reduces blood ...  -  ‎Nov 8, 2009‎
...which can occur when the body produces neutralizing antibodies against the currently marketed recombinant human erythropoietins, such as epoetin alfa or ... pharmabiz.com

Amgen 3Q Profit Up 24%  -  ‎Oct 22, 2009‎
...(Epoetin alfa) increased 5 percent to $663 million in the third quarter of 2009 versus $634 million in the third quarter of 2008 due to an increase in ... The FINANCIAL

Epo-Präparat erhöht Schlaganfallrisiko  -  ‎Nov 2, 2009‎
Auch die gleichzeitig publizierte “Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Betaâ€? oder CREATE-Studie erfüllte die Erwartungen ... Deutsches Ärzteblatt

Ratiopharm setzt sich trotz Preisdruck ehrgeizige Ziele  -  ‎Oct 25, 2009‎
Hoffnungen knüpft Windholz zum Beispiel an das zur Behandlung von Blutarmut bei Dialysepatienten eingesetzte Präparat Epoetin. ... Reuters Deutschland (Pressemitteilung)

Dialysis facility type may affect epoetin therapy  -  Apr 17, 2007
NEW YORK (Reuters Health) - The organization status and ownership of a dialysis facility appears to influence the dose of epoetin that patients with anemia ... Reuters

Novartis' Sandoz unit gains EU approval for biosimilar epoetin alfa  -  Aug 31, 2007
ZURICH (Thomson Financial) - Novartis AG said its Sandoz unit has received European Commission approval for biosimilar epoetin alfa, for the treatment of ... Forbes

… on "Does ferric gluconate lower epoetin requirements in hemodialysi...  -  Aug 28, 2008
We read with interest Dr Rajiv Agarwal's Practice Point commentary 1 on the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) II study ... Nature.com

Anemia Drugs Linked to Stroke Study Deaths: FDA  -  Sep 25, 2008
The hope was that the drug would be neuroprotective, but use of epoetin alfa now ... The new German study looked at the use of epoetin alfa as an aid to ... Forbes

Is the efficacy of epoetin beta in anemic peritoneal dialysis...  -  Jul 10, 2005
Grzeszczak W et al. (2005) The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin in peritoneal dialysis patients with chronic ... Nature.com

Simpler Anemia Treatment May Help Kidney Patients  -  Oct 19, 2007
Conventional therapy with epoetin (a synthetic form of human ... All 673 patients in the study received conventional epoetin treatment for the first four ... Washington Post

Does ferric gluconate lower epoetin requirements in hemodialysis …  -  Mar 18, 2008
The 6-week Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) study demonstrated that the administration of intravenous iron improved ... Nature.com

Heart Risk Seen in Drug for Anemia  -  Nov 16, 2006
One group received epoetin with a goal of almost fully correcting their ... The amount of epoetin received by the typical American dialysis patient has ... New York Times

Effect of treatment with epoetin beta on short-term tumour progression...  -  Jul 27, 2006
To assess the early effect of epoetin beta on survival and tumour progression in anaemic patients with cancer, data were pooled from nine randomised ... Nature.com

… with intravenous methoxy polyethylene glycol–epoetin beta in...  -  Nov 12, 2007
...(2007) Intravenous methoxy polyethylene glycol–epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a ... Nature.com

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin...  -  Jan 10, 2007
Correspondence: CA Solid, Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S-253, Minneapolis, ... Nature.com

California and the West; Payment for Amgen drugs is examined; …  -  Dec 7, 2006
Epoetin is the primary substance in anemia drugs. Because there is no clear proof that higher doses of anemia drugs produce better results, some doctors and ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

FDA Reviewing Deaths in Anemia Drug Study  -  Sep 27, 2008
Eprex is known generically as epoetin alfa. Johnson & Johnson also sells epoetin alfa under the name Procrit. Amgen sells a version under the name Epogen. ... New York Times

Ortho, Amgen Tout Anemia Drugs  -  May 15, 2005
Meanwhile, Amgen countered with data saying the final results of a study found that Aranesp administered every two weeks is as effective as epoetin alfa ... TheStreet.com - TheStreet.com (subscription)

Pure red cell aplasia due to follow-on epoetin  -  Jun 11, 2008
Correspondence: AK Singh, Renal Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA. ... Nature.com

Novartis clears EU hurdle for generic biotech drug  -  Jun 22, 2007
Epoetin alfa is marketed in Europe by Johnson & Johnson under the brand name Eprex, ... Epoetin alfa, for example, was approved by the FDA in 1989. ... MarketWatch

RADAR detects sometimes-deadly drug reactions  -  May 3, 2005
These include the anemia drug Epoetin, the cancer drug Gemcitabine and the drug Ticlopidine, used to reduce the chance of strokes. ... USA Today

Controversial Anemia Drug Doesn't Cut Need for Transfusions  -  Sep 5, 2007
The drug, epoetin alfa (brand names Epogen and Procrit) has been under ... The study authors hypothesized that giving epoetin alfa would reduce the need for ... Washington Post

Management of epoetin alpha use in the intensive care unit: a drug...  -  Sep 1, 2006
This study evaluates the appropriateness and cost implications of using epoetin alpha for transfusion reduction in Hartford Hospital's (Hartford, ... Free with registration - Formulary - AccessMyLibrary.com

Learn about Epoetin Alfa Injection from Consumer Reports Health.  -  Jan 9, 2008
All patients: Epoetin alfa increases the risk of blood clots forming in or moving to the ... Full Alert. Pending revision, the material in this section ... consumerreports.org

… dosed every two weeks is comparable to Epoetin alfa dosed weekly  -  May 16, 2005
..."This is the largest, randomized head-to-head comparison of darbepoetin alfa dosed every two weeks to Epoetin alfa dosed weekly, as they are most often used ... PsychCentral.com

J&J reports anemia drug linked to deaths in study  -  Sep 17, 2008
Epoetin alfa is the chemical name for the Eprex brand sold by another Johnson & Johnson unit outside the United States. In this country, J&J sells it under ... USA Today

The effect of epoetin dose on hematocrit  -  Nov 14, 2007
Correspondence: D Cotter, Medical Technology and Practice Patterns Institute, 4733 Bethesda Avenue, Suite 510, Bethesda, Maryland 20814, USA. ... Nature.com

… and Cost Considerations for PROCRIT(R) (Epoetin Alfa) and Darbepoeti...  -  Oct 26, 2006
A total of 25645 hospitalizations for patients with cancer were analyzed (Epoetin alfa: 22873; darbepoetin alfa: 2772), and 66822 hospitalizations for ... RedOrbit

Epoetin (Systemic).  -  Jul 28, 2005
Epoetin ( eh-POH-ee-tin) is a man-made version of human erythropoietin (EPO). EPO is produced naturally in the body, mostly by the kidneys. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Cost-Minimization Analysis of Darbepoetin Alpha vs Epoetin Alpha  -  Jan 3, 2006
Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, ... Medscape

Retacrit(R) Data Confirm Equivalent Efficacy To Epoetin Alfa In Renal...  -  Sep 8, 2008
Principal investigator of all three analyses, Professor Paul Scigalla of International Clinical Research Consulting (ICRC), commented, "These new data give ... Medical News Today - Medical News Today (press release)

… grant to explore causal relationship between epoetin dose and...  -  Feb 26, 2005
The relationship between epoetin and survival remains controversial. Currently, clinical practice guidelines recommend epoetin treatment based in part on a ... i-newswire.com

Affymax Plans Anemia Drug Studies  -  Jul 16, 2007
...with Erythropoietins, or EPO, compared to anemia treatments epoetin alpha and epoetin beta when patients switch from those treatments to Hematide. ... TheStreet.com - TheStreet.com (subscription)

… Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every ...  -  Dec 9, 2006
Shasha, D., Dawkins, F., Wilhelm, F. "Epoetin alfa 80000 U Every Three Weeks (Q3W) in Anemic Cancer Patients Not Receiving Chemotherapy or Radiation Therapy ... Medical News Today - Medical News Today (press release)

German Trial Reports 42 Deaths in Epoetin Alfa Stroke Study  -  Sep 19, 2008
By Donna Young. The anemia drug epoetin alfa has been linked to 42 deaths in patients participating in a German clinical trial testing the drug's use as a ... BioWorld Online - BioWorld Online

… grant to explore causal relationship between epoetin dose and...  -  Feb 27, 2005
The relationship between epoetin and survival remains controversial. Currently, clinical practice guidelines recommend epoetin treatment based in part on a ... News-Medical.net

Hospira wins European approval for Retacrit  -  Dec 19, 2007
Lake Forest, Illinois-based Hospira, the world's biggest maker of generic injectable pharmaceuticals, expects to launch the drug, also known as epoetin zeta ... Reuters

Epoetin Zeta Effective in Patients With Chemotherapy-Induced Anaemia:...  -  Sep 13, 2008
By Jill Stein. STOCKHOLM, Sweden -- September 13, 2008 -- Epoetin zeta is an effective treatment for chemotherapy-induced anaemia in patients with solid ... DG News

… the route of administration for Epoetin treatment among hemodialysi...  -  Jun 6, 2006
However, in the US only 7% of all hemodialysis patients receive epoetin via SC route with ... The authors found that in the US, use of SC route of epoetin ... News-Medical.net

Novartis generic anaemia drug on sale in weeks-FT  -  Sep 11, 2007
VX) expects its cut-price version of the anaemia drug epoetin alfa, or EPO, to go on sale in the UK and Germany in coming weeks, the Financial Times ... Reuters

Epoetin boosts quality of life in HIV patients.(Infectious Diseases)...  -  Feb 1, 2005
Epoetin boosts quality of life in HIV patients.(Infectious Diseases) ... find Internal Medicine News articles. WASHINGTON -- Treatment with 1 dose of ... Pay-Per-View - Internal Medicine News - HighBeam Research

Mircera (CERA) first drug to directly convert dialysis patients to...  -  Jul 17, 2006
These included two studies using epoetin alfa/beta as a comparator and one study using darbepoetin alfa.1,2,4. “This was the first Phase III registration ... webwire.com

… Dosing Regimens of PROCRIT(R) (Epoetin alfa) as Maintenance …  -  Aug 11, 2005
PROCRIT(R) (Epoetin alfa) is a prescription medication for the treatment of anemia in chronic kidney disease patients who are not on dialysis and is ... $4.95 - PR Newswire - ECNext

Epoetin and Darbepoetin for Anemia in Cancer  -  Jun 21, 2006
Anemia is a significant side effect of cancer and its therapies and occurs with treatment in 13% to 78% of patients with solid tumors and 30% to 40% of ... Medscape

Ortho Biotech Modifies Prescribing Information for PROCRIT® (Epoetin ...  -  Mar 11, 2008
Ortho Biotech Products, LP today modified prescribing information for PROCRIT® (Epoetin alfa), following guidance from the US Food and Drug Administration ... webwire.com

Sandoz Receives Positive EU Opinion For Approval Of Epoetin Alfa …  -  Jun 24, 2007
Sandoz is the first company to receive a positive opinion from European Union regulators supporting the approval of a biosimilar version of epoetin alfa, ... Medical News Today - Medical News Today (press release)

Darbepoetin, Epoetin Both Efficacious in Radiotherapy/Chemotherapy- …  -  Oct 24, 2005
By Ed Susman. DENVER, CO -- October 24, 2005 -- Researchers say the newer anti-anemia drug darbepoetin acts similarly as epoetin alfa to combat ... DG News

… Aranesp(R) Dosed Every Two Weeks Versus Epoetin Alfa Dosed Weekly  -  May 22, 2006
Amgen (NASDAQ:AMGN) announced that final results of a Phase 3 randomized, open-label head-to-head study evaluating 200 mcg of Aranesp(R) (darbepoetin alfa) ... Medical News Today - Medical News Today (press release)

Single Lot of Epoetin Alfa Recalled Due to Damaged Vials  -  Aug 6, 2008
BRIDGEWATER, NJ -- August 6, 2008 -- Ortho Biotech is announcing that it is voluntarily recalling 1 manufacturing lot (P114942A) of Epoetin alfa (Procrit) ... DG News

Mixed Results for Epoetin (Epogen or Procrit) in Critically Ill...  -  Sep 5, 2007
By Judith Groch, Senior Writer, MedPage Today. LEBANON, NH, Sept. 5 -- Epoetin alfa (Epogen or Procrit) failed to reduce the need for red-cell transfusions ... MedPage Today

Low-Dose Epoetin Beta Offers Improved Renal Anaemia Management for …  -  Nov 11, 2005
By Maria Bishop. PHILADELPHIA, PA -- November 11, 2005 -- Switching stable haemodialysis patients to a relatively low dose of NeoRecormon (epoetin beta) ... DG News

Treatment of Anemia in Chronic Kidney Disease  -  Dec 21, 2006
By 1990, recombinant human erythropoietin (epoetin) was licensed in the United ... Epoetin is administered by subcutaneous or intravenous injection 1 to 3 ... Medscape

Revisions in the prescribing information for Epoetin alfa: implication...  -  Mar 1, 2008
Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis. Pay-Per-View - Nephrology Nursing Journal - HighBeam Research

Epoetin Therapy Risks and Benefits: Just the Facts  -  Apr 24, 2007
Management of anemia in chronic kidney disease (CKD) usually involves repeated administration of epoetin or darbepoetin [erythropoiesis-stimulating agents ... Medscape

… Committee probes EPO use, dialysis costs.(epoetin alfa)(Congress...  -  Dec 11, 2006
Congressional members discussed lowering government expenses related to various forms of the anti-anemia drug epoetin alfa in the context of questioning why ... Pay-Per-View - BioWorld Week - Factiva, from Dow Jones

… Alfa Requires Fewer Dosing Changes Than Epoetin Alfa: Presented at...  -  Nov 8, 2008
By Maggie Schwarz. PHILADELPHIA -- November 8, 2008 -- Twice-monthly intravenous darbepoetin alfa requires fewer changes in dose than does epoetin alfa, ... DG News

Study Shows For-Profit Facilities Give Higher Doses of Epoetin  -  Aug 4, 2007
A study of dialysis facility ownership has revealed an association between the type of facility (profit, chain, and affiliation status) and epoetin dosing ... National Anemia Action Council

Roche Announces Successful Completion of Four Pivotal Phase III …  -  Dec 16, 2005
In these maintenance studies, patients on dialysis and on stable maintenance treatment of anemia with epoetin or darbepoetin were randomized to continue ... RedOrbit

PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of...  -  Dec 6, 2007
ATLANTA, Dec. 6 /PRNewswire/ -- Data from 11 PROCRIT(R) (Epoetin alfa) studies will be presented at the American Society of Hematology (ASH) 49th Annual ... Free with registration - PR Newswire - AccessMyLibrary.com

CERA Administered Up to Once Every Four Weeks Maintained Stable …  -  Nov 18, 2006
Mean difference in Hb from baseline for epoetin treated patients was 0.57 ... Data for epoetin treated patients showed a mean difference of 0.55 and 0.66 ... Free with registration - PR Newswire - AccessMyLibrary.com

High-Dose Epoetin Alfa (Procrit) Every 3 Weeks Effective for …  -  Dec 14, 2005
By Bruce Sylvester. ATLANTA, GA -- December 14, 2005 -- Epoetin alfa (Procrit) 80000 units administered every 3 weeks to patients on an every-3-week ... DG News

Mircera: Methoxy polyethylene glycol-epoetin beta.(New biologic)(Drug...  -  Jan 1, 2008
Endogenous erythropoietin production is impaired in patients with chronic renal failure; erythropoietin deficiency is the primary cause of anemia in these ... Free with registration - Formulary - AccessMyLibrary.com

New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced …  -  May 11, 2007
New data presented today at the 40th annual American Society of Nephrology (ASN) meeting and scientific exposition in San Francisco, CA, USA, ... ITNews

Press Release: Updated Analysis of 2001 Epoetin Alfa Study Posted. -...  -  Dec 5, 2007
Updated Analysis of 2001 Epoetin Alfa Study Posted. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced …  -  Nov 5, 2007
New data presented today at the 40th annual American Society of Nephrology (ASN) meeting and scientific exposition in San Francisco, CA, USA, ... Newswit.com

Press Release: PROCRIT(R) (Epoetin Alfa) Data to be Presented at …  -  Dec 6, 2007
PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Pivotal MIRCERA Study First to Convert Dialysis Patients From...  -  Oct 19, 2007
The results demonstrated that MIRCERA maintains haemoglobin (Hb) concentrations within the target range as effectively as ESAs epoetin alfa or beta which ... ots.at

… Prescribing Information for PROCRIT(R) (Epoetin alfa) Label...  -  Nov 8, 2007
8 /PRNewswire-FirstCall/ -- Ortho Biotech Products, LP today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the US ... Free with registration - PR Newswire - AccessMyLibrary.com

Introduction to Anemia of Chronic Kidney Disease  -  Apr 2, 2007
Epoetin alfa and darbepoetin, 2 current ESAs, are effective treatments for ... Patients also had to be taking high epoetin doses (≥ 225 IU/kg/week or ... Medscape

… Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot...  -  Aug 5, 2008
Ortho Biotech markets and distributes Epoetin alfa under the tradename . ... Article: FDA expands Epoetin alfa use to include AIDS ... ... Pay-Per-View - PR Newswire - HighBeam Research

PROCRIT(R) (Epoetin Alfa) Data to Be Presented at American Society of...  -  Nov 1, 2007
SAN FRANCISCO, Nov. 1 /PRNewswire/ -- Data from six studies of PROCRIT(R) (Epoetin alfa) will be presented at the 40th annual meeting of the American ... Free with registration - PR Newswire - AccessMyLibrary.com

Meta-analysis evaluates the effect of epoetin alfa on left ventricular...  -  Jul 1, 2005
Researchers postulated epoetin alfa may provide survival benefits and amelioration of anemia and LVH based on the findings of a meta-analysis conducted ... National Anemia Action Council

EMEA Recommends New Warning Label for Epoetin-Containing …  -  Jun 27, 2008
LONDON -- June 27, 2008 -- The European Medicines Agency (EMEA) has recommended updating the product information for epoetin-containing medicines with a new ... DG News

Erythropoietin May Increase Risk of Thromboembolism  -  May 25, 2006
In fact, the hazard ratio for mortality of 1.08 suggests that epoetin or ... They therefore suggest that "treatment with epoetin or darbepoetin to target ... Cancerpage.com

Data Support Epoetin Zeta Use in Hemodialysis Patients  -  Dec 22, 2008
Data from a German study suggest that IV-administered epoetin zeta—a new erythropoietin preparation—is safe for maintenance treatment of anemia in patients ... Renal and Urology News

Epoetin Alfa Effectively Controls Hemoglobin in Clinical Practice  -  Apr 23, 2007
April 23, 2007 — Using actual US practice patterns and dosing, epoetin alfa (Epogen; peg-EPO therapy) effectively maintains hemoglobin (Hb) levels in ... Medscape

SCCM: Epoetin Alfa Reduces Death Risk For Critically Ill Trauma...  -  Feb 19, 2007
By Michael Smith, Senior Staff Writer, MedPage Today. ORLANDO, Feb. 19 -- In critically ill trauma patients, recombinant epoetin alfa reduces mortality by ... MedPage Today

Epoetin Beta 30,000 IU Is Effective Anaemia Treatment in Haematologica...  -  Jun 10, 2007
By Jill Stein. VIENNA, AUSTRIA -- June 10, 2007 -- New findings confirm the effectiveness of weekly epoetin beta 30000 IU to treat anaemia in patients with ... DG News

Drugs for Managing Anemia Are Not Clinically Different  -  May 24, 2006
The two drugs, epoetin and darbepoetin, show no clinically significant difference ... The report, Comparative Effectiveness of Epoetin and Darbepoetin for ... newswise.com

Roche's New Long-acting ESA* For The Treatment Of Renal Anaemia …  -  May 28, 2007
Roche announced today that methoxy polyethylene glycol-epoetin beta ... Intravenous epoetin was dosed up to three times weekly compared to Roche's ... Medical News Today - Medical News Today (press release)

C-reactive protein and anemia: implications for patients on dialysis.  -  Sep 1, 2006
CRP and the Epoetin:Hb ratio were consistently higher and the Hb was lower in ... The lowest CRP and Epoetin:Hb ratio and the highest Hb levels were ... Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com

Darbepoetin Alfa and Epoetin Alfa Use in Hospitals to Combat Anemia …  -  Oct 26, 2006
By Ed Susman. SALT LAKE CITY, UT -- October 26, 2006 -- The use of erythropoiesis-stimulating protein products among hospitalized surgical patients to ... DG News

Every 2 week epoetin alpha dosing shown to be as effective as weekly...  -  Oct 1, 2006
In a 12-week, randomized open-label trial, 80000 U epoetin alfa was given to patients receiving cycled chemotherapy for non-myeloid cancer every 2 weeks ... National Anemia Action Council

Retacrit equivalent to epoetin alfa  -  Sep 9, 2008
New data showing Retacrit corrects low haemoglobin (Hb) levels as effectively and rapidly as epoetin alfa in patients with chronic kidney disease, ... Pharmacy Europe

Extended Epoetin Alfa Dosing Effects Similar in Diabetics  -  Aug 1, 2007
PATIENTS WITH and without diabetes respond similarly to extended dosing of epoetin alfa as infrequently as once every four weeks, data show. ... Renal and Urology News

Data From Investigational Use Of PROCRIT® (Epoetin Alfa) Presented At...  -  Nov 8, 2008
Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT® (Epoetin alfa) in treating anemia in subjects with ... Medical News Today - Medical News Today (press release)

FDA issues safety alerts for two cancer treatments and epoetin alfa  -  Sep 26, 2008
This week, the FDA released MedWatch alerts regarding the safety of three oncologic therapeutic agents. Chromic Phosphate P 32, erlotinib and epoetin alfa ... HemOncToday

Data From Investigational Use of PROCRIT(R) (Epoetin Alfa) Presented...  -  Nov 7, 2008
PHILADELPHIA, Nov. 7 /PRNewswire/ -- Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT(R) (Epoetin ... RedOrbit

Sandoz Receives European Commission Approval for biosimilar epoetin …  -  Sep 3, 2007
This approval was indicated for the use of biosimilar epoetin alfa in treating patients with renal anemia as well as those receiving chemotherapy. ... webwire.com

… Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety...  -  Sep 11, 2007
GAITHERSBURG, Md., Sept. 11 /PRNewswire/ -- As the Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) and Drug ... Free with registration - PR Newswire - AccessMyLibrary.com

… Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety...  -  Sep 11, 2007
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… of an anemia management program to reduce high epoetin[R] doses by...  -  Nov 1, 2008
Results of an anemia management program to reduce high epoetin[R] doses by targeted use of IV ferric gluconate.(Sponsored Educational Supplement)(Clinical ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research

Renal Anemia; Epoetin therapy during hemodialysis alters erythrocyte ...  -  Mar 12, 2005
2005 MAR 12 - (NewsRx.com & NewsRx.net) -- Epoetin therapy significantly alters erythrocyte metabolism in renal anemia patients on hemodialysis. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Pre-operative injections of epoetin-[alpha] versus post-operative …  -  Aug 1, 2008
Pre-operative injections of epoetin-[alpha] versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: A PROSPECTIVE ... Pay-Per-View - Journal of Bone and Joint Surgery - HighBeam Research

Black Box Warning Ordered for Aranesp, Epogen, and Procrit  -  Mar 9, 2007
Patients treated before surgery with epoetin alfa to reduce allogenic red ... The epoetin alfa dose was titrated to maintain a hemoglobin level of 12 to 14 ... MedPage Today

Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin...  -  Mar 8, 2008
Depending on the country in which Epoetin alfa is marketed, these indications may differ. Renal failure: Patients experienced greater risks for death and ... Free with registration - PR Newswire - AccessMyLibrary.com

… : New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced ...  -  Nov 5, 2007
New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced Angiogenic Potential. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research

… Cancer; Platinum-treated ovarian cancer patients managed with...  -  Jun 12, 2006
Patients were randomised 2:1 to receive epoetin alfa 10000-20000 IU three ... For the epoetin alfa group, mean Hb increased by 1.8 g/dl by weeks 4-6 and was ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

… of hemoglobin: the commonly used drug epoetin can help correct...  -  Mar 1, 2007
If you're an older adult with kidney disease or cancer, your doctor might have talked to you about your anemia risk. Anemia, common among older adults, ... Free with registration - Men's Health Advisor - AccessMyLibrary.com

ASN: Extended Dosing of Epoetin Alfa Appears Effective for Anemia in ...  -  Nov 7, 2008
By Todd Neale, Staff Writer, MedPage Today. PHILADELPHIA, Nov. 7 -- In chronic kidney disease, two extended dosing regimens of epoetin alfa (Procrit) worked ... MedPage Today

Press Release: PROCRIT(R) (Epoetin Alfa) Data to Be Presented at …  -  Nov 1, 2007
PROCRIT(R) (Epoetin Alfa) Data to Be Presented at American Society of Nephrology Annual Meeting. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Erythropoietin Claims Monitoring Policy: Implications of the 2006...  -  Nov 1, 2006
Under the new policy, when the Hb exceeds 13.0 g/dL, the dose of Epoetin should be ... The new guideline limits the cumulative monthly Epoetin alfa dose to ... Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com

… Prescribing Information for PROCRIT(R) (Epoetin alfa). - PR...  -  Mar 9, 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Mircera: first drug to correct anaemia in all chronic kidney disease ...  -  Nov 20, 2006
The studies used epoetin alfa/beta or darbepoetin alfa as comparator agents in a non-inferiority design1. In the first study, ARCTOS (Administration of CERA ... webwire.com





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy